Sixty-nine people have survived out-of-hospital cardiac arrests at Hawaii’s airports since an AED program was first implemented in 2006, the Oregonian reports.

Swiss drugmaker Novartis on July 29 announced its combo sacubitril/valsartan drug Entresto “narrowly missed” its primary endpoint in the Phase III PARAGON-HF study, throwing into question the future of a blockbuster drug.

Medications used to treat atrial fibrillation—namely amiodarone—could increase older patients’ risk of fainting and falling, Danish researchers have found.

KentuckyOne Health will suspend its heart transplant program at Jewish Hospital effective August 17, leaving 32 patients in Louisville, Ky., without a clear path to a new heart.

Young people who used their smartphone five or more hours per day were 43% more likely to be obese than their counterparts with less reported screen time in a recent study presented at the ACC Latin American Conference 2019 in Cartagena, Colombia.

A group of researchers from Harvard Medical School and the Yale School of Medicine have debunked the idea of a “July effect” in cardiac surgery with a study of nearly half a million U.S.-based heart procedures.

Despite lower risks for other CVD risk factors, former National Football League players are nearly six times more likely than their non-NFL peers to develop atrial fibrillation, according to a study published in the Journal of the American Heart Association.

Australian researchers have uncovered yet another link between the controversial Paleolithic diet and heart disease.